+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Latin America Contraceptives Market 2019-2027

  • ID: 4772827
  • Report
  • Region: Latin America
  • 88 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 3

FEATURED COMPANIES

  • Afaxys, Inc.
  • Allergan Inc.
  • Church & Dwight Co., Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Okamoto Industries, Inc
  • MORE
Market Outlook

The research report on the Latin American contraceptives market has come to the conclusion that this market is anticipated to escalate at a CAGR of 7.57% during the forecast years 2019-2027. Brazil, Mexico and rest of Latin America have been analyzed in the Latin American market region.

Several factors have been responsible for the growth of this market, the major ones being the birth control awareness initiatives taken by the government, easy availability of oral contraceptive pills, openness to adopt modern methods of contraception and the need to avoid unintended pregnancies and STIs. The consumption of contraceptives, however, comes with the risk of causing side-effects such as breast cancer, hair loss, nausea, depression, blood clots, etc., and has been a major restraining factor for the contraceptives market growth.

The Latin American contraceptives market can be segregated into various categories on the basis of education, age group, end users and drugs & devices. As per the age group, the market can be further divided into people falling in the age ranges 15-24, 25-34, 35-44 and 45 and above. The report contains detailed analysis of factors such as market definition, Porter’s five forces analysis, Regulatory outlook, market attractiveness index, key insights, and market player positioning.

The increase in the disposable incomes of the individuals who are conscious of their sexual well-being is a factor that provides an opportunity for the growth of the contraceptive market. Technological breakthroughs in the development of contraceptives for both males and females have increased their efficacy, safety and reliability. These technologically advanced contraceptives provide a higher success rate.

Competitive Outlook

The top key companies in the contraceptives manufacturing market are Merck & Co., Inc., Church & Dwight Co., Inc., Pfizer, Inc., Ocon Medical, Ltd., Cooper Surgical, Inc., Mayer Laboratories, Inc., Melbea, Okamoto Industries, Inc., Teva Pharmaceutical Industries, Ltd., SMB Corporation, Agile Therapeutics, Apothecus Pharmaceutical Corporation, Allergan, Inc., Afaxys, Inc., Reckitt Benckiser PLC, Bayer AG and Pregna.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Afaxys, Inc.
  • Allergan Inc.
  • Church & Dwight Co., Inc.
  • Mayer Laboratories, Inc.
  • Merck & Co., Inc.
  • Okamoto Industries, Inc
  • MORE
1. Contraceptive Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitute
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Threat of Competitive Rivalry
2.3. Regulatory Outlook
2.4. Pestel Outlook
2.5. Market Attractiveness Index
2.6. Market Player Positioning
2.7. Key Insights
2.7.1. Oral Contraceptive Are the Majorly Used Contraceptive Drugs
2.7.2. Condoms Are the Widely Used Contraceptives Device
2.7.3. Age Group of 15–24 Years Are the Major Revenue Contributors to the Latin America Contraceptive Market
2.8. Market Drivers
2.8.1. Growing Cognizance For Contraceptives
2.8.2. Increasing Usage of Oral Contraceptives to Evade Unplanned Pregnancy
2.8.3. Surge in the Initiatives of Government and Ngo
2.8.4. Growing Awareness About Std
2.9. Market Restraints
2.9.1. Side Effects Restricting the Growth of Contraceptives
2.9.2. Limited Access to Contraceptives
2.10. Market Opportunities
2.10.1. Rising Disposable Income in Emerging Economies
2.10.2. Unmet Medical Needs in the Emerging Economies
2.10.3. Technological Advancements
2.11. Market Challenges
2.11.1. Lack of Acceptance of Society

3. Contraceptive Market Outlook - By Education
3.1. Less Than High School
3.2. High School Graduate
3.3. College Graduate
3.4. Other College Degrees

4. Contraceptive Market Outlook - By Age Group
4.1. 15–24 Years
4.2. 25–34 Years
4.3. 35–44 Years
4.4. Above 44 Years

5. Contraceptive Market Outlook - By End User
5.1. Households
5.2. Clinics
5.3. Hospitals

6. Contraceptive Market Outlook - By Drugs and Devices
6.1. Contraceptives Drugs
6.1.1. Oral Contraceptive Pills
6.1.2. Injectable Contraceptives
6.1.3. Topical Contraceptives
6.2. Contraceptive Devices
6.2.1. Male Condoms
6.2.2. Female Condoms
6.2.3. Diaphragms
6.2.4. Contraceptive Sponges
6.2.5. Vaginal Rings
6.2.6. Subdermal Implants
6.2.7. Intra-Uterine Devices
6.2.7.1. Copper Intra-Uterine Devices
6.2.7.2. Hormonal Intra-Uterine Devices

7. Contraceptive Market - Regional Outlook
7.1. Latin America
7.1.1. Country Analysis
7.1.1.1. Brazil
7.1.1.2. Mexico
7.1.1.3. Rest of Latin America

8. Competitive Landscape
8.1. Company Profiles
8.1.1. Allergan Inc.
8.1.2. Bayer Ag
8.1.3. Melbea
8.1.4. Pregna
8.1.5. Pfizer, Inc.
8.1.6. Church & Dwight Co., Inc.
8.1.7. Afaxys, Inc.
8.1.8. Apothecus Pharmaceutical Corporation
8.1.9. Cooper Surgical Inc
8.1.10. Okamoto Industries, Inc
8.1.11. Mayer Laboratories, Inc.
8.1.12. Agile Therapeutics
8.1.13. Merck & Co., Inc.
8.1.14. Reckitt Benckiser Plc
8.1.15. Smb Corporation
8.1.16. Teva Pharmaceutical Industries Ltd.
8.1.17. Ocon Medical Ltd

9. Methodology & Scope
9.1. Research Scope
9.2. Sources of Data
9.3. Research Methodology

List of Tables
Table 1 Latin America Contraceptive Market 2019-2027 ($ Million)
Table 2 Contraceptive Market Player Positioning Outlook 2017
Table 3 Latin America Contraceptive Market By Education 2019-2027 ($ Million)
Table 4 Latin America Contraceptive Market By Age Group 2019-2027 ($ Million)
Table 5 Latin America Contraceptive Market By End User 2019-2027 ($ Million)
Table 6 Latin America Contraceptive Market By Drugs and Devices 2019-2027 ($ Million)
Table 7 Latin America Contraceptives Drugs Market By Type 2019-2027 ($ Million)
Table 8 Latin America Contraceptive Devices Market By Type 2019-2027 ($ Million)
Table 9 Latin America Intra-Uterine Devices Market By Type 2019-2027 ($ Million)
Table 10 Latin America Contraceptive Market By Country 2019-2027 ($ Million)

List of Figures
Figure 1 Latin America Contraceptive Market 2019-2027 ($ Million)
Figure 2 Porter's Five Force Model
Figure 3 Latin America Contraceptive Market By Less Than High School 2019-2027 ($ Million)
Figure 4 Latin America Contraceptive Market By High School Graduate 2019-2027 ($ Million)
Figure 5 Latin America Contraceptive Market By College Graduate 2019-2027 ($ Million)
Figure 6 Latin America Contraceptive Market By Other College Degrees 2019-2027 ($ Million)
Figure 7 Latin America Contraceptive Market By 15–24 Years 2019-2027 ($ Million)
Figure 8 Latin America Contraceptive Market By 25–34 Years 2019-2027 ($ Million)
Figure 9 Latin America Contraceptive Market By 35–44 Years 2019-2027 ($ Million)
Figure 10 Latin America Contraceptive Market By Above 44 Years 2019-2027 ($ Million)
Figure 11 Latin America Contraceptive Market By Households 2019-2027 ($ Million)
Figure 12 Latin America Contraceptive Market By Clinics 2019-2027 ($ Million)
Figure 13 Latin America Contraceptive Market By Hospitals 2019-2027 ($ Million)
Figure 14 Latin America Contraceptive Market By Contraceptives Drugs 2019-2027 ($ Million)
Figure 15 Latin America Contraceptives Drugs Market By Oral Contraceptive Pills 2019-2027 ($ Million)
Figure 16 Latin America Contraceptives Drugs Market By Injectable Contraceptives 2019-2027 ($ Million)
Figure 17 Latin America Contraceptives Drugs Market By Topical Contraceptives 2019-2027 ($ Million)
Figure 18 Latin America Contraceptive Market By Contraceptive Devices 2019-2027 ($ Million)
Figure 19 Latin America Contraceptive Devices Market By Male Condoms 2019-2027 ($ Million)
Figure 20 Latin America Contraceptive Devices Market By Female Condoms 2019-2027 ($ Million)
Figure 21 Latin America Contraceptive Devices Market By Diaphragms 2019-2027 ($ Million)
Figure 22 Latin America Contraceptive Devices Market By Contraceptive Sponges 2019-2027 ($ Million)
Figure 23 Latin America Contraceptive Devices Market By Vaginal Rings 2019-2027 ($ Million)
Figure 24 Latin America Contraceptive Devices Market By Subdermal Implants 2019-2027 ($ Million)
Figure 25 Latin America Contraceptive Devices Market By Intra-Uterine Devices 2019-2027 ($ Million)
Figure 26 Latin America Intra-Uterine Devices Market By Copper Intra-Uterine Devices 2019-2027 ($ Million)
Figure 27 Latin America Intra-Uterine Devices Market By Hormonal Intra-Uterine Devices 2019-2027 ($ Million)
Figure 28 Brazil Contraceptive Market 2019-2027 ($ Million)
Figure 29 Mexico Contraceptive Market 2019-2027 ($ Million)
Figure 30 Rest of Latin America Contraceptive Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Inc.
  • Bayer AG
  • Melbea
  • Pregna
  • Pfizer, Inc.
  • Church & Dwight Co., Inc.
  • Afaxys, Inc.
  • Apothecus Pharmaceutical Corporation
  • Cooper Surgical Inc
  • Okamoto Industries, Inc
  • Mayer Laboratories, Inc.
  • AGile Therapeutics
  • Merck & Co., Inc.
  • Reckitt Benckiser plc
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • Ocon Medical
Note: Product cover images may vary from those shown
Adroll
adroll